Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) Earnings
Price: $25.03
Market Cap: $25.03B
Market Cap: $25.03B
Revenue (TTM): $18.61B
Net Income: $2.14B
Net Income: $2.14B
P/E Ratio: 11.07
EPS (TTM): $2.26
EPS (TTM): $2.26
Earnings Dates
Genomma Lab Internacional, S.A.B. de C.V (LABB.MX) reports its earnings quarterly. Here are the key details:
Next Earnings Date
- Date: April 22, 2025
- Time of Day: Before Market Open
- Estimated EPS: $N/A
Last Earnings Report
- Date: February 26, 2025
- EPS: $0.50
- EPS Estimate: $0.59
Genomma Lab Internacional, S.A.B. de C.V's next earnings report is scheduled for April 22, 2025.
In its last earnings report on February 26, 2025, Genomma Lab Internacional, S.A.B. de C.V reported earnings per share (EPS) of $0.50, compared to an estimated EPS of $0.59. The company reported revenue of $4.67B, compared to an estimated revenue of $4.74B.
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|
Earnings History
| Date | EPS | EPS Estimate | Revenue | Revenue Estimate |
|---|---|---|---|---|
| February 26, 2025 | $0.50 | $0.59 | $4.67B | $4.74B |
| October 23, 2024 | $0.70 | $0.49 | $5.09B | $- |
| July 24, 2024 | $0.67 | $0.45 | $4.65B | $4.52B |
| April 24, 2024 | $0.39 | $0.42 | $4.20B | $4.37B |
| February 21, 2024 | $-0.12 | $0.17 | $3.53B | $3.80B |
| October 25, 2023 | $0.39 | $0.46 | $4.39B | $4.31B |
| July 26, 2023 | $0.43 | $0.42 | $4.37B | $4.27B |
| April 26, 2023 | $0.37 | $0.38 | $4.18B | $4.16B |
| February 22, 2023 | $0.27 | $0.39 | $4.13B | $- |
| October 26, 2022 | $0.40 | $0.43 | $4.35B | $- |
| July 27, 2022 | $0.40 | $0.43 | $4.32B | $- |
| April 27, 2022 | $0.34 | $0.45 | $4.01B | $- |
| February 23, 2022 | $0.36 | $0.41 | $15.49B | $- |
| October 27, 2021 | $0.39 | $0.42 | $3.98B | $- |
| July 28, 2021 | $0.38 | $0.40 | $3.87B | $- |
| April 28, 2021 | $0.32 | $0.37 | $3.55B | $- |
| February 24, 2021 | $0.33 | $0.32 | $13.87B | $- |
Annual Earnings
Annual Revenue
$18.61B
Fiscal Year 2024Annual Net Income
$2.14B
Fiscal Year 2024Annual EPS
$2.26
Fiscal Year 2024Quarterly Earnings
Revenue
$4.67B
Quarter Ending December 31, 2024Net Income
$473.49M
Quarter Ending December 31, 2024EPS
$0.50
Quarter Ending December 31, 2024Earnings Metrics
Earnings Yield
8.93%
Year Ending December 31, 2024P/E Ratio
11.20
Year Ending December 31, 2024Revenue Per Share
$19.69
Year Ending December 31, 2024Earnings Yield (TTM)
9.04%
Trailing Twelve MonthsP/E Ratio (TTM)
11.07
Trailing Twelve MonthsRevenue Per Share (TTM)
$19.69
Trailing Twelve MonthsFrequently Asked Questions
Genomma Lab Internacional, S.A.B. de C.V's next earnings date is scheduled for April 22, 2025. The earnings call is expected to take place before market open.
In its last earnings report on February 26, 2025, Genomma Lab Internacional, S.A.B. de C.V reported earnings per share (EPS) of $0.50, compared to an estimated EPS of $0.59. The company reported revenue of $4.67B, compared to an estimated revenue of $4.74B.
Genomma Lab Internacional, S.A.B. de C.V's current Price-to-Earnings (P/E) ratio is 11.20. The trailing twelve months (TTM) P/E ratio is 11.07. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.
For the fiscal year ending December 31, 2024, Genomma Lab Internacional, S.A.B. de C.V reported total revenue of $18.61B and net income of $2.14B. This represents a net profit margin of 0.114866187.
Genomma Lab Internacional, S.A.B. de C.V's earnings yield is 8.93%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.
Genomma Lab Internacional, S.A.B. de C.V's return on equity (ROE) is 18.44%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.
Genomma Lab Internacional, S.A.B. de C.V's gross profit margin is 64.12%. This indicates that for every dollar of revenue, the company retains $0.64 as gross profit after accounting for the cost of goods sold.
Related Metrics
Explore detailed financial metrics and analysis for LABB.MX.